Literature DB >> 22688186

Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells.

Kanako Nishimura1, Shuho Semba, Kazuhiko Aoyagi, Hiroki Sasaki, Hiroshi Yokozaki.   

Abstract

OBJECTIVE: Accumulating evidences suggest that cancer-associated fibroblasts are provided from bone-marrow-derived mesenchymal stem cells (BM-MSCs); however, little is known about the mechanism(s) by which BM-MSCs accelerate cancer aggressiveness.
METHODS: Gastric carcinoma (GC)-derived MKN-7 cells were cocultured with UE6E7T-12 BM-MSCs. The gene expression profile in MKN-7 cells was investigated by microarray analysis. Between two major types of GCs (intestinal- and diffuse-type), the expression of genes was detected by immunohistochemistry.
RESULTS: We found that direct attachment to UE6E7T-12 induced proliferation and cluster formation of MKN-7 cells. Coculture with UE6E7T-12 increased the population of CD133+ MKN-7 cells in vitro and coimplantation of these in mice resulted in subcutaneous tumors in vivo. The wingless-type MMTV integration site (WNT) family member 5A (WNT5A) and transforming growth factor-β (TGF-β)-induced (TGFBI) genes were found to be upregulated in MKN-7 cells directly attached to UE6E7T-12. Recruitment of CD271+ BM-MSC was detected preferentially in the stroma of the diffuse-type GC and this type of GC cell also showed frequent expression of WNT5A, TGF-β type I receptor and CD133.
CONCLUSION: BM-MSC-mediated activations of the WNT and TGF-β signaling pathways were thought to provide advantageous microenvironments for cancer progression by supporting the reacquisition and maintenance of cancer stem cells.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22688186     DOI: 10.1159/000337296

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  34 in total

1.  Perspectives of gene combinations in phenotype presentation.

Authors:  Shihori Tanabe
Journal:  World J Stem Cells       Date:  2013-07-26       Impact factor: 5.326

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Mesenchymal stem cells in the tumor microenvironment.

Authors:  Jian Guan; Jie Chen
Journal:  Biomed Rep       Date:  2013-05-10

4.  Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.

Authors:  F Böhrnsen; M Fricke; C Sander; A Leha; H Schliephake; F J Kramer
Journal:  Clin Oral Investig       Date:  2014-10-28       Impact factor: 3.573

5.  Regulated genes in mesenchymal stem cells and gastric cancer.

Authors:  Shihori Tanabe; Kazuhiko Aoyagi; Hiroshi Yokozaki; Hiroki Sasaki
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 6.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

7.  Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation.

Authors:  Sofia Avnet; Gemma Di Pompo; Tokuhiro Chano; Costantino Errani; Arig Ibrahim-Hashim; Robert J Gillies; Davide Maria Donati; Nicola Baldini
Journal:  Int J Cancer       Date:  2017-03-15       Impact factor: 7.396

Review 8.  The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.

Authors:  Jun Ye; Dang Wu; Pin Wu; Zhigang Chen; Jian Huang
Journal:  Tumour Biol       Date:  2014-01-14

Review 9.  Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.

Authors:  Kisha Nandini Sivanathan; Stan Gronthos; Darling Rojas-Canales; Benjamin Thierry; P Toby Coates
Journal:  Stem Cell Rev Rep       Date:  2014-06       Impact factor: 5.739

10.  Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy.

Authors:  Jun Zhao; Mark Z Ma; Hening Ren; Zhenqiu Liu; Martin J Edelman; Hong Pan; Li Mao
Journal:  Clin Cancer Res       Date:  2013-05-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.